Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases
- PMID: 34095730
- PMCID: PMC8164456
- DOI: 10.1002/ags3.12428
Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases
Abstract
Aim: We investigated the prognostic impact of osteosarcopenia, which is the combination of osteopenia and sarcopenia, in patients with colorectal liver metastases (CRLM) after hepatic resection.
Methods: One hundred and eighteen patients were analyzed retrospectively. Osteopenia was evaluated with computed tomographic measurement of pixel density in the midvertebral core of the 11th thoracic vertebra. Sarcopenia was evaluated with psoas muscle areas at the third lumbar vertebra. Osteosarcopenia was defined as the concomitant occurrence of osteopenia and sarcopenia.
Results: Osteosarcopenia was identified in 38 (32%) of the patients. In univariate analysis, the overall survival was significantly worse in patients with lymph node metastases (P = .01), extrahepatic lesion (P = .01), sarcopenia (P = .02), osteosarcopenia (P < .01), Glasgow Prognostic Score (GPS) 1 or 2 (P = .05), and curability R 1 or 2 (P = .04). In multivariate analysis, lymph node metastases (P < .01), osteosarcopenia (P < .01), and GPS 1 or 2 (P = .03) were independent and significant predictors of the overall survival. In patients with osteosarcopenia, there were more women than men and body mass index was lower compared to patients without osteosarcopenia.
Conclusion: Osteosarcopenia was the strong predictor for outcomes in patients who underwent liver resection for CRLM.
Keywords: colorectal liver metastases; liver resection; osteopenia; osteosarcopenia; sarcopenia.
© 2021 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery.
Conflict of interest statement
Conflict of Interest: The authors have no conflicts of interest and funding to declare.
Figures




Similar articles
-
Osteosarcopenia in patients with cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2024 Nov 8;103(45):e40476. doi: 10.1097/MD.0000000000040476. Medicine (Baltimore). 2024. PMID: 39533564 Free PMC article.
-
The significance of osteosarcopenia as a predictor of the long-term outcomes in hepatocellular carcinoma after hepatic resection.J Hepatobiliary Pancreat Sci. 2023 Apr;30(4):453-461. doi: 10.1002/jhbp.1246. Epub 2022 Oct 19. J Hepatobiliary Pancreat Sci. 2023. PMID: 36181339
-
Prognostic impact of osteosarcopenia in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma.Langenbecks Arch Surg. 2024 Apr 18;409(1):130. doi: 10.1007/s00423-024-03315-x. Langenbecks Arch Surg. 2024. PMID: 38634913
-
Osteosarcopenia predicts poor prognosis for patients with intrahepatic cholangiocarcinoma after hepatic resection.Surg Today. 2023 Jan;53(1):82-89. doi: 10.1007/s00595-022-02550-3. Epub 2022 Jul 13. Surg Today. 2023. PMID: 35831486
-
Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease.Life (Basel). 2021 Aug 30;11(9):899. doi: 10.3390/life11090899. Life (Basel). 2021. PMID: 34575048 Free PMC article. Review.
Cited by
-
Osteosarcopenia is a significant predictor of recurrence and the prognosis after resection for extrahepatic bile duct cancer.Surg Today. 2024 May;54(5):407-418. doi: 10.1007/s00595-023-02747-0. Epub 2023 Sep 12. Surg Today. 2024. PMID: 37700170
-
Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Resection.Ann Surg Oncol. 2023 Oct;30(11):6673-6679. doi: 10.1245/s10434-023-13936-z. Epub 2023 Jul 19. Ann Surg Oncol. 2023. PMID: 37466870
-
Osteosarcopenia in patients with cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2024 Nov 8;103(45):e40476. doi: 10.1097/MD.0000000000040476. Medicine (Baltimore). 2024. PMID: 39533564 Free PMC article.
-
Predictive value of osteopenia as prognostic marker for survival and recurrence in patients with gastrointestinal cancers: a systematic review and meta-analysis.Front Med (Lausanne). 2025 May 1;12:1527829. doi: 10.3389/fmed.2025.1527829. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40375934 Free PMC article.
-
Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis.Arch Osteoporos. 2022 Feb 11;17(1):33. doi: 10.1007/s11657-022-01060-6. Arch Osteoporos. 2022. PMID: 35149903 Free PMC article.
References
LinkOut - more resources
Full Text Sources